Here is a compiled review of the most significant insider trading activity reported for Monday, July 6, 2026. The filings detail meaningful purchases by company insiders and a 10% investor, as well as large-scale disposals executed largely under pre-arranged Rule 10b5-1 trading plans. The activity covers a range of market capitalizations and trading contexts as reported in recent Form 4 filings.
Top buys
Mink Brook Asset Management LLC - DLH Holdings Corp. (NASDAQ:DLHC)
Mink Brook Asset Management LLC, identified as a 10% owner of DLH Holdings Corp., increased its stake through open market purchases that together totaled $78,479. According to the Form 4 filing, the firm acquired 5,640 shares of DLH Holdings common stock on July 2, 2026. The shares were bought at a weighted average price of $5.2477 per share. Individual transaction prices reported in the filing ranged from $5.21 to $5.25, and the filing also notes prices in the range of $5.1881 to $5.2477. At the time of reporting the company’s shares trade near a 52-week low of $5.12, with the latest quoted price at $5.13 for the company, which carries a market capitalization of $74 million.
Robert Baltera Jr. - Palisade Bio, Inc. (NASDAQ:PALI)
Director Robert Baltera Jr. disclosed purchases of 30,000 shares of Palisade Bio common stock across transactions on July 1 and July 2, 2026. The total consideration for these purchases was reported at $59,400. The shares were acquired at a weighted average price of $1.98 per share, with specific transaction prices recorded between $1.97 and $1.99. At the time of the filing Palisade Bio shares were trading at $2.04, a level that sits close to the company’s 52-week high of $2.85. The stock has returned 181% over the past year, a rise the filing describes as occurring amid significant volatility.
Maimon Shalom Arik - Cuentas Inc. (NASDAQ:CUEN)
Cuentas Inc. Chief Executive Officer Maimon Shalom Arik disclosed multiple open market purchases totaling $2,011 in value, executed over two days on July 1 and July 2, 2026. The CEO purchased 5,200 shares of the company’s common stock with transaction prices ranging from $0.35 to $0.45 per share. The timing of these purchases coincided with a notable short-term rally in the company’s share price; the filing notes the stock returned 61% over the past week. The filing also characterizes the company’s shares as generally trading with high price volatility.
Top sells
Manuel Alba - Astera Labs, Inc. (NASDAQ:ALAB)
Astera Labs director Manuel Alba disclosed the sale of common stock amounting to approximately $60.5 million on July 1, 2026. The transactions involved 129,916 shares sold at prices ranging from $429.578 to $459.0178 per share, with the stock trading near a reported price of $432.74. The filing points out that the stock has climbed 383% over the past year. The sales were executed automatically under a Rule 10b5-1 trading plan that Mr. Alba adopted on May 29, 2025. The Form 4 indicates that the shares are owned indirectly by Manuel Alba-Marquez in trust for the Alba 2003 Living Trust, for which Mr. Alba and his spouse serve as co-trustees. The filing also states that Mr. Alba disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Benoit Dageville - Snowflake Inc. (NASDAQ:SNOW)
Snowflake director Benoit Dageville reported sales totaling approximately $48.6 million on July 2, 2026. The shares were sold at a single reported price of $254.64 per share. The filing shows the transactions comprised the direct sale of 140,819 shares and the indirect sale of 50,000 shares held by The Snow Trust, for which Mr. Dageville is a trustee. The filing indicates these sales were carried out under a pre-arranged 10b5-1 trading plan adopted on April 3, 2026. The company’s stock has advanced 19.5% year-to-date and was trading near its 52-week high of $285 at the time of reporting. The filing includes an InvestingPro assessment that the stock appears overvalued relative to its Fair Value.
April S. Arnzen - Micron Technology Inc. (NASDAQ:MU)
Micron Technology Executive Vice President and Chief People Officer April S. Arnzen sold a total of 40,000 shares of common stock on July 1, 2026. The aggregate value of the transactions was reported at $43,357,473. The sales occurred across several transactions with reported prices ranging from $1,077.00 to $1,096.00 per share. The filing notes these disposals were executed under a Rule 10b5-1 trading plan adopted by Ms. Arnzen on December 19, 2025.
Andreas Bechtolsheim - Arista Networks, Inc. (NASDAQ:ANET)
Andreas Bechtolsheim, a 10% owner of Arista Networks, disclosed the sale of common stock valued at approximately $42.7 million on July 1, 2026. The filings report the disposition of 260,000 shares, executed under a pre-arranged Rule 10b5-1 trading plan that the filing notes was established on February 20, 2026. The shares were sold in multiple transactions at prices ranging from $159.8465 to $170.2653 per share. The filing indicates the sales were conducted indirectly through a family trust for which Mr. Bechtolsheim serves as trustee. At the time of reporting, Arista Networks was trading near a 52-week high of $179.80 and the filing lists the stock as having returned 69% over the past year. The filing also provides a reported P/E ratio for the company of 58.87.
Matthew Prince - Cloudflare, Inc. (NASDAQ:NET)
Cloudflare Chief Executive Officer and Board Co-Chair Matthew Prince reported sales of Class A Common Stock totaling roughly $21.1 million across multiple transactions on July 2 and July 6, 2026. The filing records the sale of 86,014 shares at prices ranging from $239.035 to $250.43 per share. At the time of the filing Cloudflare’s stock was quoted at $247.72 and the filing notes the stock has gained 25.56% year-to-date and trades 56% above its 52-week low of $158.83. The sales were executed under a Rule 10b5-1 trading plan established on February 26, 2026. The filing cites InvestingPro analysis indicating the stock appears overvalued relative to its Fair Value and lists the company among those on a Most Overvalued list.
Context and considerations
The recent Form 4 filings show a mixture of small and large-dollar insider purchases alongside substantial sales, many of which were carried out under pre-arranged 10b5-1 trading plans. The filings include both direct and indirect ownership structures, with several sales routed through trusts and with trustees named. Reported trading prices in the filings are presented alongside company trading levels such as current prices and 52-week highs or lows where available. Several filings also reference InvestingPro assessments regarding relative valuation compared to Fair Value.
While insider purchases are often regarded as indicators of confidence, and insiders’ sales may be read as signaling concerns or an effort to rebalance personal holdings, the Form 4 disclosures in these filings also underscore that insiders execute transactions for a variety of reasons. The filings explicitly note that many sales were carried out automatically pursuant to Rule 10b5-1 plans, and that insiders may disclaim beneficial ownership except for their pecuniary interests where applicable. These details highlight that the timing and size of disclosed trades can reflect pre-arranged plans, trust arrangements, estate considerations or other personal financial planning needs.
Summary
Form 4 disclosures for July 1 through July 6, 2026 indicate targeted purchases by a 10% owner and company directors at small-cap and micro-cap companies, and sizable sales by executives and large shareholders at larger tech names. Several sales were conducted pursuant to Rule 10b5-1 trading plans, and indirect ownership through trusts was reported in multiple filings. The disclosed transactions span stocks trading near 52-week highs and lows, and include InvestingPro commentary within some filings regarding apparent overvaluation relative to Fair Value.
Key points
- Insiders and a 10% holder disclosed meaningful purchases at DLH Holdings, Palisade Bio and Cuentas, while executives and large shareholders disclosed large sales at several technology companies.
- Several large sales were executed under Rule 10b5-1 pre-arranged trading plans and involved indirect holdings held in trusts.
- The activity covered names trading near short-term lows and others near 52-week highs, with multiple filings noting InvestingPro assessments on relative valuation.
Risks and uncertainties
- Rule 10b5-1 plans can automate sales and limit the informational value of timing in individual transactions - this affects interpretation for equities across the technology and semiconductor sectors where several sales were reported.
- Indirect ownership structures and trust arrangements complicate assessment of beneficial ownership and intent, particularly for large sales in trust-held positions at several technology companies.
- Valuation commentary included in some filings indicates possible overvaluation relative to Fair Value, a factor that may influence both insider disposition decisions and investor perception in impacted sectors.